From the UK - 2a

摘要

A compound according to formula I: EMI FILE = "02095898_1" ID = "1" IMF = JPEG where Z is selected from the group consisting of H, R11, OR11, OC (O) R11, OC (O) OR11; and OC (O) NR11R12, OC (O) NR11-12R12-11; R11 is selected from the group consisting of C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C3-C8 cycloalkyl, aryl, and heteroaryl; R12 is selected from the group consisting of H, C1-C6 alkyl, C3-C6 cycloalkyl, C2-C5 alkenyl, and C2-C5 alkynyl; NR11-12R12-11 is a 5-8 membered ring, where the ring members are selected from the group comprising C, O, and S; Q is selected from the group comprising H, CH3, CH2CH3, CF3, Ph, CH = CH2,Mm was selected from h, CH3, ch2ch3, CF3, pH, CH2 or cycloacrylonitrile group; t was selected from O, OC (o) group.OC (O) O S SC (O)SC (O) O, or EMI FILE = "02095898_2" ID = "2" IMF = JPEG G is selected from the group consisting of H, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-cycloalkyl C6, aryl, and heteroaryl; optionally, G and M can form a 3-8 membered carbocyclic system; optionally, M and Q can form a 3 to 8 membered carbocyclic system; where each alkyl, alkoxy, alkenyl, alkynyl , cycloalkyl, cycloalkenyl, benzyl, aryl, and heteroaryl can be substituted with one or more substituents. A process comprising using a composition comprising a compound according to claim 1, in a phytologically acceptable and disease inhibiting amount,In order to prevent, control or eradicate psychic diseases